Skip to main content
Clinical Trials/NCT05467150
NCT05467150
Recruiting
Not Applicable

Maternal Probiotic Supplementation for Improved Neurodevelopmental Outcomes in Infants of Diabetic Mothers (IDMs)

University of Minnesota1 site in 1 country60 target enrollmentOctober 17, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infant of Diabetic Mother
Sponsor
University of Minnesota
Enrollment
60
Locations
1
Primary Endpoint
Infant VEP performance at 6 months: latency to peak of P100
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memory abnormalities.

Registry
clinicaltrials.gov
Start Date
October 17, 2022
End Date
August 31, 2026
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant people in their second or third trimester with a diagnosis of gestational diabetes.
  • BMI 18.5-45 kg/m2 at first prenatal visit
  • Age 21-45 at time of delivery
  • Report social support for and intention to exclusively breastfeed for at least 3 months
  • Singleton pregnancy

Exclusion Criteria

  • Alcohol consumption \>1 drink per week during pregnancy/lactation
  • Tobacco consumption during pregnancy/lactation
  • Inability to speak/understand English
  • Known congenital metabolic, endocrine disease (other than GDM), or congenital illness affecting infant feeding
  • History of type I Diabetes
  • Birthing parent currently taking over the counter probiotic preparation

Outcomes

Primary Outcomes

Infant VEP performance at 6 months: latency to peak of P100

Time Frame: 6 months of age

The main component of interest in the VEP waveform is a large positive wave peaking at about 100 ms (P100). We will be looking at the latency to the peak of the P100 component (milliseconds) as a measure of speed of processing.

Infant auditory recognition ERP performance at 1 month: P200 amplitude

Time Frame: 1 month of age

At one month of age, an auditory recognition memory ERP will be performed. Components of interest will be the P200 amplitude (in microvolts) The P200 is a positive component of the ERP waveform and a measure of early perceptual processing of stimuli.

Infant auditory recognition ERP performance at 1 month: Negative slow wave difference score

Time Frame: 1 month of age

At one month of age, an auditory recognition memory ERP will be performed. Components of interest will be latency in milliseconds. The area under the curve of the negative slow wave (NSW, a late slow-resolving component if the ERP waveform, which is thought to index detection of a novel stimulus against the background of familiar stimuli).

Infant visual recognition ERP performance at 6 months: Slow wave difference score

Time Frame: 6 months of age

At 6 months of age, visual-evoked potential ERP paradigms will be performed. We will be measuring the latency and amplitude of the N290, a negative component occurring between 150-400ms (representing face processing), the amplitude of the negative central (NC) component, occurring between 350-700ms and thought to index attention, and the area under the curve of the slow-resolving positive component occurring between 900-1500ms that indexes memory updating.

Study Sites (1)

Loading locations...

Similar Trials